怪物饮料 MNST 深 沪
已收盘 12-12 16:00:00 美东时间
73.97
+1.480
+2.04%
华盛通- 最 高74.315
- 今 开72.94
- 成交量 485.56万股
- 最 低 72.76
- 昨 收 72.49
- 总市值 722.69亿
- 52周最高 76.279
- 市盈率 静 49.66
- 换手率 0.50%
- 52周最低 45.70
- 委 比 85.44%
- 总股本 9.77亿
- 历史最高 76.279
- 量 比 1.00
- 振 幅 2.15%
- 历史最低 5.7383
- 每 手 1
- 风险率 7.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Stifel Maintains Buy on Monster Beverage, Raises Price Target to $82
Stifel analyst Matthew Smith maintains Monster Beverage (NASDAQ:MNST) with a Buy and raises the price target from $78 to $82.
12-12 23:58
美股大行评级 | 美鹰服饰、CrowdStrike、迈威尔科技获多家机构上调目标价；ACHC、GitLab、Okta遭多家机构下调目标价
今日重点评级关注：Guggenheim：维持Cybin Inc. Common Shares"买入"评级，目标价从39美元升至48美元；HC Wainwright & Co.：维持Capricor Therapeutics"买入"评级，目标价从24美元升至60美元
12-04 09:38
Monster Beverage Hosts Investor Meeting Webcast
Monster Beverage ( ($MNST) ) just unveiled an announcement. On December 2, 2025...
12-03 04:17
美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
12-02 09:50
Quality stocks present “once in a generation” opportunity – top stocks as per SA Quant
Investors facing historically high stock market valuations now have a rare opportunity to invest in quality stocks, said Ruchir Sharma, Rockefeller International chairman and Breakout Capital founder ...
12-02 00:46
RBC Capital Maintains Outperform on Monster Beverage, Raises Price Target to $81
RBC Capital analyst Nik Modi maintains Monster Beverage (NASDAQ:MNST) with a Outperform and raises the price target from $75 to $81.
12-01 22:29
Catalyst Watch: Holiday shopping data, Amazon event, and Salesforce earnings
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - December ...
11-29 02:30
Peering Into Monster Beverage Corp's Recent Short Interest
Monster Beverage Corp's (NYSE:MNST) short interest as a percent of float has ri...
11-19 02:00
Monster Beverage, UnitedHealth, Thermo Fisher Scientific And More: CNBC's 'Final Trades'
Today's "Final Trades" segment focused on UnitedHealth, Thermo Fisher Scientific, iShares U.S. Healthcare ETF and Monster Beverage.
11-18 21:08
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
11-11 10:49
